JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CMRX
4926
DELISTED
Chimerix, Inc.
CMRX
| $57K | ﹤0.01% |
15,563
-261,508
| -94% | -$805K |
2013 Q2
24 quarters
|
|
|
FUV
4927
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $57K | ﹤0.01% |
+916
| New | +$63.8K |
2019 Q2
0 quarters
|
|
|
USAK
4928
DELISTED
USA Truck Inc
USAK
| $57K | ﹤0.01% |
5,795
-56,961
| -91% | -$751K |
2017 Q3
7 quarters
|
|
4929
Cytosorbents Corp
CTSO
$12.4M
| $56K | ﹤0.01% |
421
+58
| +16% | +$7.97K |
2018 Q2
4 quarters
|
|
4930
Liquidity Services
LQDT
$1.36B
| $56K | ﹤0.01% |
9,369
+1,457
| +18% | +$9.28K |
2013 Q2
24 quarters
|
|
|
NESR
4931
National Energy Services Reunited Corp
NESR
$2.44B
| $56K | ﹤0.01% |
6,516
-7,088
| -52% | -$67.6K |
2019 Q1
1 quarter
|
|
|
VWTR
4932
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $56K | ﹤0.01% |
5,025
-28,550
| -85% | -$316K |
2016 Q4
10 quarters
|
|
|
TTPH
4933
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $56K | ﹤0.01% |
5,821
+5,177
| +804% | +$95.3K |
2017 Q3
7 quarters
|
|
4934
WisdomTree Emerging Markets Local Debt Fund
ELD
$137M
| $55K | ﹤0.01% |
1,566
-167,229
| -99% | -$5.72M |
2015 Q1
17 quarters
|
|
4935
Green Brick Partners
GRBK
$2.84B
| $55K | ﹤0.01% |
6,679
+694
| +12% | +$6.25K |
2017 Q4
6 quarters
|
|
4936
iShares Morningstar Small-Cap Value ETF
ISCV
$666M
| $55K | ﹤0.01% |
1,218
| – | – |
2015 Q2
16 quarters
|
|
4937
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.1B
| $55K | ﹤0.01% |
776
| – | – |
2017 Q4
6 quarters
|
|
|
AGTC
4938
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $55K | ﹤0.01% |
14,700
+11,500
| +359% | +$47.1K |
2018 Q2
4 quarters
|
|
|
ATHX
4939
DELISTED
Athersys, Inc. Common Stock
ATHX
| $55K | ﹤0.01% |
1,407
-442
| -24% | -$18.1K |
2017 Q4
6 quarters
|
|
|
ENFC
4940
DELISTED
Entegra Financial Corp.
ENFC
| $55K | ﹤0.01% |
1,852
+144
| +8% | +$4.04K |
2017 Q4
6 quarters
|
|
4941
DHI Group
DHX
$210M
| $54K | ﹤0.01% |
+14,047
| New | +$48.7K |
2019 Q2
0 quarters
|
|
|
PWOD
4942
DELISTED
Penns Woods Bancorp
PWOD
| $54K | ﹤0.01% |
1,884
+210
| +13% | +$5.9K |
2016 Q4
10 quarters
|
|
4943
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.16B
| $54K | ﹤0.01% |
1,079
-735
| -41% | -$36.7K |
2017 Q4
6 quarters
|
|
|
MRNS
4944
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $54K | ﹤0.01% |
3,446
+580
| +20% | +$10.1K |
2018 Q1
5 quarters
|
|
|
ATCO
4945
DELISTED
Atlas Corp.
ATCO
| $54K | ﹤0.01% |
5,742
+5,612
| +4,317% | +$54K |
2018 Q2
4 quarters
|
|
|
MFSF
4946
DELISTED
MutualFirst Financial Inc
MFSF
| $54K | ﹤0.01% |
1,626
-1,129
| -41% | -$34.2K |
2016 Q4
10 quarters
|
|
4947
WisdomTree US SmallCap Earnings Fund
EES
$696M
| $53K | ﹤0.01% |
1,500
| – | – |
2018 Q4
2 quarters
|
|
4948
iShares Global Clean Energy ETF
ICLN
$2.26B
| $53K | ﹤0.01% |
5,000
| – | – |
2016 Q4
10 quarters
|
|
4949
iShares MSCI Intl Quality Factor ETF
IQLT
$13.7B
| $53K | ﹤0.01% |
1,750
-1,361
| -44% | -$40.3K |
2018 Q4
2 quarters
|
|
|
MPX
4950
DELISTED
Marine Products Corp
MPX
| $53K | ﹤0.01% |
3,344
-8,174
| -71% | -$121K |
2017 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.